Preparation and optimization of doxorubicin-loaded albumin nanoparticles using response surface methodology

References

• Cho K, Wang X, Nie S, Chen ZG, Shin DM. (2008). Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res, 14:1310–1316.
   PubMed Web of Science ®Google Scholar
• Singal PK, Li T, Kumar D, Danelisen I, Iliskovic N. (2000). Adriamycininduced heart failure: mechanism and modulation. Mol Cell Biochem, 207:77–86.
   PubMed Web of Science ®Google Scholar
• Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. (2004). Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev, 56:185–229.
   PubMed Web of Science ®Google Scholar
• Gelperina SE, Khalansky AS, Skidan IN, Smirnova ZS, Bobruskin AI, Severin SE et al. (2002). Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma. Toxicol Lett, 126:131–141.
   PubMed Web of Science ®Google Scholar
• Steiniger SC, Kreuter J, Khalansky AS, Skidan IN, Bobruskin AI, Smirnova ZS et al. (2004). Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int J Cancer, 109:759–767.
   PubMed Web of Science ®Google Scholar
• Cuvier C, Roblot-Treupel L, Millot JM, Lizard G, Chevillard S, Manfait M et al. (1992). Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance. Biochem Pharmacol, 44:509–517.
   PubMed Web of Science ®Google Scholar
• Leo E, Cameroni R, Forni F. (1999). Dynamic dialysis for the drug release evaluation from doxorubicin-gelatin nanoparticle conjugates. Int J Pharm, 180:23–30.
   PubMed Web of Science ®Google Scholar
• Yoo HS, Oh JE, Lee KH, Park TG. (1999). Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release. Pharm Res, 16:1114–1118.
   PubMed Web of Science ®Google Scholar
• Plank C, Mechtler K, Szoka FC, Wagner E. (1996). Activation of the complement system by synthetic DNA complexes: A potential barrier for intravaneous gene delivery. Human Gene Ther, 7:1437–1446.
   PubMed Web of Science ®Google Scholar
• Orson FM, Kinsey BM, Hua PJ, Bhogal BS, Densmore CL, Barry MA. (2000). Genetic immunization with lung-targeting macroaggregated polyethyleneimine–albumin conjugates elicits combined systemic an mucosal immune responses. J Immunol, 164:6313–6321.
   PubMed Web of Science ®Google Scholar
• Orson FM, Song L, Gautam A, Densmore CL, Bhogal BS, Kinsey BM. (2002). Gene delivery to the lung using protein/polyethylenimine/plasmid complexes. Gene Ther, 9:463–471.
   PubMed Web of Science ®Google Scholar
• Truong-Le VL, Walsh SM, Schweibert E, Mao HQ, Guggino WB, August JT et al. (1999). Gene transfer by DNA-gelatin nanospheres. Arch Biochem Biophys, 361:47–56.
   PubMed Web of Science ®Google Scholar
• Simões S, Slepushkin V, Pires P, Gaspar R, Pedroso de Lima MC, Düzgünes N. (2000). Human serum albumin enhances DNA transfection by lipoplexes and confers resistance to inhibition by serum. Biochim Biophys Acta, 1463:459–469.
   PubMed Web of Science ®Google Scholar
• Weber C, Coester C, Kreuter J, Langer K. (2000). Desolvation process and surface characterisation of protein nanoparticles. Int J Pharm, 194:91–102.
   PubMed Web of Science ®Google Scholar
• Langer K, Balthasar S, Vogel V, Dinauer N, von Briesen H, Schubert D. (2003). Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm, 257:169–180.
   PubMed Web of Science ®Google Scholar
• Nobs L, Buchegger F, Gurny R, Allémann E. (2004). Current methods for attaching targeting ligands to liposomes and nanoparticles. J Pharm Sci, 93:1980–1992.
   PubMed Web of Science ®Google Scholar
• Wartlick H, Michaelis K, Balthasar S, Strebhardt K, Kreuter J, Langer K. (2004). Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells. J Drug Target, 12:461–471.
   PubMed Web of Science ®Google Scholar
• Dinauer N, Balthasar S, Weber C, Kreuter J, Langer K, von Briesen H. (2005). Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes. Biomaterials, 26:5898–5906.
   PubMed Web of Science ®Google Scholar
• Steinhauser I, Spänkuch B, Strebhardt K, Langer K. (2006). Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells. Biomaterials, 27:4975–4983.
   PubMed Web of Science ®Google Scholar
• Gallo JM, Hung CT, Perrier DG. (1984). Analysis of albumin microsphere preparation. Int J Pharm, 22:63–74.
   Web of Science ®Google Scholar
• Lin W, Coombes AG, Davies MC, Davis SS, Illum L. (1993). Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method. J Drug Target, 1:237–243.
   PubMed Web of Science ®Google Scholar
• Müller BG, Leuenberger H, Kissel T. (1996). Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique. Pharm Res, 13:32–37.
   PubMed Web of Science ®Google Scholar
• Westcott CC. (1978). pH Measurements. New York, USA: Academic Press.
   Google Scholar
• Kristo E, Biliaderis CG, Tzanetakis N. (2003). Modeling of the acidification process and rheological properties of milk fermented with a yogurt starter culture using response surface methodology. Food Chem, 83:437–446.
   Web of Science ®Google Scholar
• Beg QK, Saxena RK, Gupta R. (2002). Kinetic constants determination for an alkaline protease from Bacillus mojavensis using response surface methodology. Biotechnol Bioeng, 78:289–295.
   PubMed Web of Science ®Google Scholar
• Lai LST, Pan CC, Tzeng BK. (2003). The influence of medium design on lovastatin production and pellet formation with a high-producing mutant of Aspergillus terreus in submerged cultures. Process Biochem, 38:1317–1326.
   Web of Science ®Google Scholar
• Soo EL, Salieh AB, Basri M. (2004). Response surface methodological study on lipasecatalyzed synthesis of amino acid surfactants. Process Biochem, 39:1151–1518.
   Google Scholar
• Wang YX, Lu ZX. (2005). Optimization of processing parameters for the mycelial growth and extracellular polysaccharide production by Boletus spp. ACCC 50328. Process Biochem, 40:1043–1051.
   Web of Science ®Google Scholar
• Preetha B, Viruthagiri T. (2007). Application of response surface methodology for the biosorption of copper using Rhizopus arrhizus. J Hazard Mater, 143:506–510.
   PubMed Web of Science ®Google Scholar
• Mannan S, Fakhrul-Razi A, Alam MZ. (2007). Optimization of process parameters for the bioconversion of activated sludge by Penicillium corylophilum, using response surface methodology. J Environ Sci (China), 19:23–28.
   PubMed Web of Science ®Google Scholar
• Chang JS, Tsai YH, Wu PC, Huang YB. (2007). The effect of mixed-solvent and terpenes on percutaneous absorption of meloxicam gel. Drug Dev Ind Pharm, 33:984–989.
   PubMed Web of Science ®Google Scholar
• Pan CM, Fan YT, Xing Y, Hou HW, Zhang ML. (2008). Statistical optimization of process parameters on biohydrogen production from glucose by Clostridium sp. Fanp2. Bioresour Technol, 99:3146–3154.
   PubMed Web of Science ®Google Scholar
• Shah SN, Asghar S, Choudhry MA, Akash MS, ur Rehman N, Baksh S. (2009). Formulation and evaluation of natural gum-based sustained release matrix tablets of flurbiprofen using response surface methodology. Drug Dev Ind Pharm, 35:1470–1478.
   PubMed Web of Science ®Google Scholar
• Liu CH, Wu CT, Fang JY. (2010). Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery. Drug Dev Ind Pharm, 36:751–761.
   PubMed Web of Science ®Google Scholar
• Kim MS, Kim JS, You YH, Park HJ, Lee S, Park JS et al. (2007). Development and optimization of a novel oral controlled delivery system for tamsulosin hydrochloride using response surface methodology. Int J Pharm, 341:97–104.
   PubMed Web of Science ®Google Scholar
• Myers RH, Montgomery DC. (2002). Response Surface Methodology, 2nd Edition. New york, USA: John Wiley & Sons.
   Google Scholar
• Harris PL, Cuppett SL, Bullerman LB. (1990). Optimization of lipase synthesis by Pseudomonas fluorescens by response surfacemethodology. J Food Protect, 53:481–483.
   Web of Science ®Google Scholar
• Lescure F, Zimmer C, Roy R, Couveur P. (1992). Optimization of poly(alkylcyanoacrylate) nanoparticles: influence of sulphur dioxide and pH on nanoparticles characteristics. J Colloid Interf Sci, 154:77–86.
   Web of Science ®Google Scholar
• Armstrong NA, James KC. (1990). Understanding Experimental Design and Interpretation in Pharmaceutics. Ellis Horwood, Chichester, UK.
   Google Scholar
• Lin W, Garnett MC, Davis SS, Schacht E, Ferruti P, Illum L. (2001). Preparation and characterisation of rose Bengal-loaded surface-modified albumin nanoparticles. J Control Release, 71:117–126.
   PubMed Web of Science ®Google Scholar
• Haley B, Frenkel E. (2008). Nanoparticles for drug delivery in cancer treatment. Urol Oncol, 26:57–64.
   PubMed Web of Science ®Google Scholar
• Sun JX, Wang LN, Yin L, Zhang ZX. (2004). Determination of 10-hydroxycamptothecin in tissues of rats by HPLC-FD. J China Pharm Univ, 35:540–544.
   Google Scholar
• Vergnaud JM. (1993). Controlled Drug Release of Oral Dosage Forms. Chicster, UK: Ellis Horwood.
   Google Scholar
• Dhiman MK, Yedurkar PD, Sawant KK. (2008). Buccal bioadhesive delivery system of 5-fluorouracil: optimization and characterization. Drug Dev Ind Pharm, 34:761–770.
   PubMed Web of Science ®Google Scholar